Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2474890 | 1.00 | HTT (0.53) | HTTALDH1A1MEN1KMT2ATHRB | |
| 2-Ethoxyethanol SCHEMBL14320335 | 0.92 | ALDH1A1 (0.56) | HTTALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL10710700 | 0.88 | ALDH1A1 (0.61) | HTTALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL15965441 | 0.86 | ALDH1A1 (0.64) | HTTALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL2441539 | 0.86 | — | — | |
| SCHEMBL10712147 | 0.84 | ALDH1A1 (0.54) | HTTALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL10867319 | 0.84 | ALDH1A1 (0.54) | HTTALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL1471751 | 0.82 | HTT (0.59) | HTTALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL13989308 | 0.80 | HTT (0.60) | HTTALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL10712690 | 0.80 | ALDH1A1 (0.59) | HTTALDH1A1MEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2372017-B1 | SOFTENER COMPOSITION | KAO CORP (JP) | 2017-09-13 | — | — | EP | disclosed |
| US-8497235-B2 | Softener composition comprising ethoxylated esterquats | KAO CORPORATION (JP) | 2013-07-30 | — | — | US | disclosed |
| US-20110263476-A1 | SOFTENER COMPOSITION | KAO CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| EP-2372017-A1 | SOFTENER COMPOSITION | Kao Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263476-A1 | SOFTENER COMPOSITION | H1-0, H1-10, H1-2 | HTT 877/4885ALDH1A1 3671/4885MEN1 2902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.